Inhibition of Tunneling Nanotube (TNT) Formation and Human T-cell Leukemia Virus Type 1 (HTLV-1) Transmission by Cytarabine

Sci Rep. 2018 Jul 24;8(1):11118. doi: 10.1038/s41598-018-29391-w.

Abstract

The human T-cell leukemia virus type 1 (HTLV-1) is highly dependent on cell-to-cell interaction for transmission and productive infection. Cell-to-cell interactions through the virological synapse, biofilm-like structures and cellular conduits have been reported, but the relative contribution of each mechanism on HTLV-1 transmission still remains vastly unknown. The HTLV-1 protein p8 has been found to increase viral transmission and cellular conduits. Here we show that HTLV-1 expressing cells are interconnected by tunneling nanotubes (TNTs) defined as thin structures containing F-actin and lack of tubulin connecting two cells. TNTs connected HTLV-1 expressing cells and uninfected T-cells and monocytes and the viral proteins Tax and Gag localized to these TNTs. The HTLV-1 expressing protein p8 was found to induce TNT formation. Treatment of MT-2 cells with the nucleoside analog cytarabine (cytosine arabinoside, AraC) reduced number of TNTs and furthermore reduced TNT formation induced by the p8 protein. Intercellular transmission of HTLV-1 through TNTs provides a means of escape from recognition by the immune system. Cytarabine could represent a novel anti-HTLV-1 drug interfering with viral transmission.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / drug effects
  • Actins / genetics
  • Cell Communication / genetics*
  • Cell Communication / immunology
  • Cytarabine / pharmacology
  • Gene Products, tax / genetics
  • HTLV-I Infections / genetics*
  • HTLV-I Infections / transmission
  • HTLV-I Infections / virology
  • Human T-lymphotropic virus 1 / drug effects
  • Human T-lymphotropic virus 1 / genetics*
  • Human T-lymphotropic virus 1 / pathogenicity
  • Humans
  • Immune System
  • Jurkat Cells / virology
  • Leukemia, T-Cell / genetics
  • Leukemia, T-Cell / pathology
  • Leukemia, T-Cell / virology
  • Nanotubes / chemistry*
  • T-Lymphocytes / immunology
  • Tubulin / genetics*
  • Viral Proteins / genetics

Substances

  • Actins
  • Gene Products, tax
  • Tubulin
  • Viral Proteins
  • Cytarabine